| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Advantage Insurance (AVI) | TBA | $150.00 | n.a. | |||
| Aptinyx (APTX) | J.P. Morgan/ Cowen/ Leerink Partners/ BMO Capital Markets | $80.00 | n.a. | |||
| AVROBIO (AVRO) | Morgan Stanley/ Cowen/ Wells Fargo Securities | $86.25 | n.a. | |||
| Carbon Natural Gas (CRBO) | RBC Capital Markets, LLC | $75.00 | n.a. | |||
| Eidos Therapeutic (EIDX) | J.P. Morgan/ BofA Merrill Lynch | $115.00 | n.a. | |||
| Electrocore (ECOR) | Piper Jaffray/ Evercore ISI | $74.75 | n.a. | |||
| Essential Properties Realty Trust (EPRT) | Goldman Sachs/ Citigroup/ Barclays | $100.00 | n.a. | |||
| Far Point Acquisition (FPAC.U) (u) | Credit Suisse/ BofA Merrill Lynch | 40.00 | $10.00 | $10.00 | $400.00 | n.a. |
| Focus Financial Partners (FOCS) | Goldman Sachs/ BofA Merrill Lynch/ KKR/ BMO Capital Markets/ RBC Capital Markets/ SunTrust Robinson Humphrey | $100.00 | n.a. | |||
| HyreCar (HYRE) | Network 1 Financial Securities | 2.00 | $5.00 | $6.00 | $11.00 | n.a. |
| i3 Verticals (IIIV) | Cowen/ Raymond James/ KeyBanc Capital Markets | $85.80 | n.a. | |||
| Kezar Life Sciences (KZR) | Jefferies/ Cowen/ Wells Fargo Securities/ William Blair | $80.50 | n.a. | |||
| Magenta Therapeutics (MGTA) | J.P. Morgan/ Goldman Sachs/ Cowen | $100.00 | n.a. | |||
| Verrica Pharmaceuticals (VRCA) | BofA Merrill Lynch/ Jefferies/ Cowen | $86.25 | n.a. | |||
| Xeris Pharmaceuticals (XERS) | Jefferies/ Leerink Partners/ RBC Capital Markets | $75.00 | n.a. | |||
| n.a. (not available) | ||||||
| TBA (to be announced) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| SoulCycle (SLCY) | Goldman Sachs/ BofA Merrill Lynch/ Citigroup | $100.00 | n.a. | |||
| New Terms | ||||||
| M17 Entertainment Limited (YQ) | Citigroup/ Deutsche Bank Securities | 7.51 | $10.00 | $12.00 | $82.62 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of May 21, 2018 | Manager(s) | Offered | Raised | Price | 5/25/18 | Change |
| EVO Payments (EVOP) | J.P. Morgan/ BofA Merrill Lynch/ Citigroup/ Deutsche Bank Securities/ SunTrust Robinson Humphrey/ Barclays/ Cowen/ Goldman Sachs/ Regions Securities/ William Blair | 14.00 | $224.00 | $16.00 | $19.80 | 23.75% |
| Kiniksa Pharmaceuticals (KNSA) | Goldman Sachs/ J.P. Morgan | 8.50 | $153.00 | $18.00 | $19.41 | 7.83% |
| GreenSky (GSKY) | Goldman Sachs/ J.P. Morgan/ Morgan Stanley/ BofA Merrill Lynch/ Citigroup/ Credit Suisse/ SunTrust Robinson Humphrey | 38.00 | $874.00 | $23.00 | $24.77 | 7.70% |
| Scholar Rock Holding (SRRK) | Jefferies/ Cowen/ BMO Capital Markets | 5.36 | $75.10 | $14.00 | $15.00 | 7.14% |
| CLPS Incorporation (CLPS) | Benchmark/ Cuttone | 2.00 | $10.50 | $5.25 | $5.40 | 2.86% |
| Iterum Therapeutics plc (ITRM) | Leerink Partners/ RBC Capital Markets | 6.15 | $79.95 | $13.00 | $12.85 | -1.15% |
